YBL-003

N/A

Report date: 2025/01/02 16:12:17

Base Information

Drug NameYBL-003
Drug Alias NameYBL-003
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-V-set and immunoglobulin domain-containing protein 4Immune checkpoint inhibitors
TargetsV-set and immunoglobulin domain-containing protein 4
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPierre Fabre LtdY-biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesY-biologics IncPierre Fabre Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A